Next, we treated TMZ-resistant glioma cells with both MK2206 and siCDKN1A, as shown in Figure 6D, 6E, the inhibitory effect on p-CDKN1A expression was remarkably increased by combinational treatment. This evidence concerns the gene CDKN1A and glioma.